Document Detail

Effect of selective thromboxane synthetase inhibitor on vein grafts.
MedLine Citation:
PMID:  3686135     Owner:  NLM     Status:  MEDLINE    
We evaluated the effect of a selective thromboxane synthetase inhibitor (TSI) on the patency of autogenous vein grafts in dogs. Treatment involved oral dosing (10 mg/kg bid) of TSI or placebo, combined with local treatment of the graft with TSI or placebo (papavarine) at the time of implantation. At harvest, two animals, one from each oral dosing group, had an occluded graft; both grafts had been locally treated with papavarine. We found no significant histopathologic difference between graft treatment groups. Attempts to estimate the effect of TSI dosing on the prostacyclin/thromboxane balance through radioimmunoassay analysis of graft perfusates were unsuccessful. As measured by in vitro platelet aggregation, oral TSI was found to alter platelet function, though not in a dose-dependent fashion, and the animals rebounded toward normal at 12 hours.
M Cargile; S L Neyman; R F Hebeler; R Askins; J P O'Leary
Related Documents :
7581115 - High-dose cyclosporine and corticosteroids for prophylaxis of acute and chronic graft-v...
9787945 - How to convert from traditional cyclosporine to the microemulsion formulation in stable...
21057555 - Influence of comorbidities on transplant outcomes in patients aged 50 years or more aft...
10336505 - Pharmacokinetic advantage of intra-arterial cyclosporin a delivery to vascularly isolat...
23649375 - Reactive increase in gastric mucus secretion is an adaptive defense mechanism against l...
2688155 - Relative biological effectiveness (rbe) of p(26) + be neutrons from the king faisal spe...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  80     ISSN:  0038-4348     ISO Abbreviation:  South. Med. J.     Publication Date:  1987 Nov 
Date Detail:
Created Date:  1987-12-21     Completed Date:  1987-12-21     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1355-9     Citation Subset:  AIM; IM    
Department of Surgery, Baylor University Medical Center, Dallas, Tex. 75246.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Benzofurans / pharmacology*
Blood Vessel Prosthesis*
Graft Occlusion, Vascular / prevention & control*
Iliac Artery / surgery
Jugular Veins / transplantation*
Platelet Aggregation / drug effects
Thromboxane-A Synthase / antagonists & inhibitors*
Vascular Patency / drug effects*
Reg. No./Substance:
0/Benzofurans; 85666-17-7/furegrelate; EC Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Spontaneous bacterial peritonitis: variant syndromes.
Next Document:  Hypoprothrombinemia associated with cefoperazone therapy.